Proof of Usefulness Report

Calluna Pharma

Analysis completed on 2/4/2026

+394
Proof of Usefulness Score
Certified Problem Solver

Calluna Pharma is a verified, legitimate clinical-stage biotechnology company formed by the merger of Oxitope Pharma and Arxx Therapeutics (Jan 2024), with €75M in Series A funding and a lead candidate (CAL101) in Phase 2 trials for idiopathic pulmonary fibrosis. However, the project submission itself is of extremely low quality, containing false data (Team Size: '0', Traction: 'most people', Reach: 'everyone') and likely submitted by an automated or unauthorized source ('ShadowHeart'). The score reflects the high real-world utility and verified traction of the underlying entity, severely penalized by the hallucinated claims and poor response quality of the submission.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+203
Audience Reach Impact+24
Technical Innovation+81
Evidence Of Traction+64
Market Timing Relevance+54
Functional Completeness+2
Subtotal+428
Usefulness Multiplierx0.92
Final Score+394

Project Details

Project URL
callunapharma.com
Description
Calluna Pharma is a clinical-stage biotechnology company focused on developing novel therapies for inflammatory and fibrotic diseases. Formed in January 2024 through the merger of Oxitope Pharma and Arxx Therapeutics, the company targets upstream innate immune amplifiers to disrupt disease-associated signaling pathways. Calluna's pipeline includes several first-in-class therapeutic antibodies, with its lead candidate CAL101 aiming to neutralize the S100A4 protein, implicated in conditions like idiopathic pulmonary fibrosis and chronic kidney disease.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline